New progress in research and prevention of respiratory syncytial virus infection in children / 上海预防医学
Shanghai Journal of Preventive Medicine
; (12): 1158-1164, 2022.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-953915
Biblioteca responsável:
WPRO
ABSTRACT
Respiratory syncytial virus (RSV) is the most important viral pathogen causing acute lower respiratory tract infections in children under 5 years of age and poses a serious threat to infant health. After more than 60 years, the development of RSV vaccines and monoclonal antibodies has been moving forward amid bumps. Recently, several RSV vaccines and monoclonal antibodies have entered phase Ш clinical trials, which brings light to the prevention of RSV. We reviewed the new progress in research and prevention of RSV, so as to provide help for the prevention and control of RSV.
Texto completo:
Disponível
Contexto em Saúde:
Agenda de Saúde Sustentável para as Américas
Problema de saúde:
Objetivo 10: Doenças transmissíveis
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Shanghai Journal of Preventive Medicine
Ano de publicação:
2022
Tipo de documento:
Artigo